During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

Most of us breathe without a second thought, but for millions of people across this world, every breath reminds them of the ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

Chronic obstructive pulmonary disease (COPD), a condition that affects more than 14 million U.S. adults, is marked by damage ...

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolled SAN FRANCISCO and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., ...

Researchers reported that a lung MRI technique that uses inhaled gas can identify early patchy lung defects in patients with ...

Fisher & Paykel is well-positioned to benefit from long-term growth prospects in hospital and home respiratory care. Increasing adoption of nasal high flow, or NHF, therapy in the hospital division is ...

A growing number of U.S veterans, desperate to treat PTSD, are turning to psychedelics. They're headed to other countries, where the drugs are more accessible for help.

We sifted through stock screeners, online rankings, and ETFs to compile a list of 30 cancer stocks. We then selected the top ...

This is the first major breakthrough in 50 years. British researchers have just discovered a new treatment for severe forms ...

Upgrades aim to improve asthma relief and COPD treatment with advanced technology.United States, January 31, 2025 -- TruNeb ...